145 related articles for article (PubMed ID: 6307906)
1. Ploidy as a prognostic factor in ovarian cancer.
Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
3. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
4. DNA flow cytometric analysis of serous ovarian tumors of low malignant potential.
Seidman JD; Norris HJ; Griffin JL; Hitchcock CL
Cancer; 1993 Jun; 71(12):3947-51. PubMed ID: 8508360
[TBL] [Abstract][Full Text] [Related]
5. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.
Lindmark G; Glimelius B; Påhlman L; Enblad P
Int J Colorectal Dis; 1991 May; 6(2):115-20. PubMed ID: 1875120
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Kaern J; Tropé CG; Kristensen GB; Pettersen EO
Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
[TBL] [Abstract][Full Text] [Related]
8. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
9. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
11. Ploidy as a prognostic determinant in surgically treated lung cancer.
Zimmerman PV; Hawson GA; Bint MH; Parsons PG
Lancet; 1987 Sep; 2(8558):530-3. PubMed ID: 2887832
[TBL] [Abstract][Full Text] [Related]
12. Analysis of subclonal expansion of colorectal carcinomas by flow cytometry.
Sugai T; Nakamura S; Habano W; Uesugi N; Sato H; Funato O; Sasou S; Orii S; Itoh C
Virchows Arch; 1999 May; 434(5):437-41. PubMed ID: 10389627
[TBL] [Abstract][Full Text] [Related]
13. Ploidy analysis of epithelial ovarian cancers using image cytometry.
Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
15. DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer.
Osterheld MC; Caron L; Demierre M; Laurini R; Bosman FT
Cell Oncol; 2004; 26(1-2):21-9. PubMed ID: 15371654
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy analysis of borderline epithelial ovarian tumours.
Lodhi S; Najam S; Pervez S
J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral DNA heterogeneity correlated with lymph node involvement and surgical staging in epithelial ovarian cancer by flow cytometry.
Takahashi Y; Takenaka A; Ishiguro T; Noda Y
Cancer; 1994 Jun; 73(12):3011-4. PubMed ID: 8199997
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of DNA content in human ovarian cancers.
Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
